China's game-changing pharmaceutical and biot...

AI tools were expected to help companies work faster, spend less money, and become more productive. But what happens when employees use so much AI that costs become too high? In this episode, Skip Montreux and Dez Morgan look at tokenmaxxing — a new business problem where AI cost ...  Show more

Guyana has become one of the world’s fastest-growing economies after major offshore oil discoveries transformed its economic outlook. In this episode, we look at how this small South American country is managing a sudden oil boom — and the opportunities and risks that come with i ...  Show more

China’s biotech industry is booming. Driven by vast government funding and Western partnerships, the country is introducing new commercial drugs at a faster pace than ever before. But could controversial topics such as human genetic engineering derail its accelerated growth? Shan ...  Show more

Our China Healthcare Analyst Jack Lin discusses how China’s biotech surge is reshaping healthcare, investment and innovation worldwide.Read more insights from Morgan Stanley.----- Transcript ----- Jack Lin: Welcome to Thoughts on the Market. I'm Jack Lin, from Morgan Stanley's Ch ...  Show more

Dr Patterson will review the background to the pharmaceutical crisis and the different ways that companies are approaching the issues. The lecture will review both the research and development and business issues facing the industry and its investors. The Pharmaceutical industry ...  Show more

What’s next for cancer treatment and personalized medicine? How is AI reshaping the future of drug discovery? And can Europe keep pace with China’s rapid rise in health care innovation? In this episode, Nicolai welcomes Thomas Schinecker, CEO of Roche, one of the world’s large ...